Masanari Kato

1.2k total citations
48 papers, 929 citations indexed

About

Masanari Kato is a scholar working on Molecular Biology, Surgery and Oncology. According to data from OpenAlex, Masanari Kato has authored 48 papers receiving a total of 929 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 13 papers in Surgery and 9 papers in Oncology. Recurrent topics in Masanari Kato's work include Immune Response and Inflammation (5 papers), Salivary Gland Tumors Diagnosis and Treatment (5 papers) and Peptidase Inhibition and Analysis (4 papers). Masanari Kato is often cited by papers focused on Immune Response and Inflammation (5 papers), Salivary Gland Tumors Diagnosis and Treatment (5 papers) and Peptidase Inhibition and Analysis (4 papers). Masanari Kato collaborates with scholars based in Japan, United States and India. Masanari Kato's co-authors include Fuminori Kato, Yuichi Hashimoto, Shaun A. Nguyen, Terry A. Day, Hiroyuki Miyachi, Evren Erkul, Rumiko Shimazawa, Shigehiro Morikawa, Ikuo Tooyama and Naoko Watanabe and has published in prestigious journals such as SHILAP Revista de lepidopterología, The Journal of Immunology and PLoS ONE.

In The Last Decade

Masanari Kato

41 papers receiving 888 citations

Peers

Countries citing papers authored by Masanari Kato

Since Specialization

Citations

This map shows the geographic impact of Masanari Kato's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Masanari Kato with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Masanari Kato more than expected).

Fields of papers citing papers by Masanari Kato

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Masanari Kato. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Masanari Kato. The network helps show where Masanari Kato may publish in the future.

Co-authorship network of co-authors of Masanari Kato

This figure shows the co-authorship network connecting the top 25 collaborators of Masanari Kato. A scholar is included among the top collaborators of Masanari Kato based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Masanari Kato. Masanari Kato is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Outcomes After Exoscopic Versus Microscopic Ossicular Chain Reconstruction 2024 ·Otology & Neurotology ·(unknown), (unknown), Robert M. Conway, Masanari Kato, Seilesh C. Babu	1
2	Outcomes After Exoscopic Versus Microscopic Type 1 Tympanoplasty 2024 ·Otology & Neurotology ·Caleb J. Fan, (unknown), (unknown), Robert M. Conway, Masanari Kato, Seilesh C. Babu	0
3	Outcomes and prognostic factors for parotid acinic cell Carcinoma: A National Cancer Database study of 2362 cases 2018 ·Oral Oncology ·Claudia Scherl, Masanari Kato, Evren Erkul, Evan M. Graboyes, Shaun A. Nguyen, C. Angela, (unknown), Terry A. Day	34
4	Clinical features of ectomesenchymal chondromyxoid tumors: A systematic review of the literature 2017 ·Oral Oncology ·Masanari Kato, Evren Erkul, (unknown), (unknown), Shaun A. Nguyen, Terry A. Day	15
5	A CASE OF IDIOPATHIC PENUMOPERITONEUM DUE TO A FALL TRAUMA 2010 ·Nihon Rinsho Geka Gakkai Zasshi (Journal of Japan Surgical Association) ·(unknown), Masanari Kato, (unknown), Hiroshi Akimoto	1
6	Relationship between the tautomeric structures of curcumin derivatives and their Aβ-binding activities in the context of therapies for Alzheimer's disease 2010 ·Biomaterials ·Daijiro Yanagisawa, Nobuaki Shirai, (unknown), Hiroyasu Taguchi, Koichi Hirao, Makoto Urushitani, Shigehiro Morikawa, Toshiro Inubushi, Masanari Kato, Fuminori Kato, (unknown), Hirohiko Kimura, (unknown), Chikako Yoshida, Takashi Okada, Mitsuo Sano, Yoshiko Wada, Kennosuke Wada, Akitsugu Yamamoto, Ikuo Tooyama	131
7	Nine Cases of Spontaneous Esophageal Rupture 2008 ·Nihon Kyukyu Igakukai Zasshi Journal of Japanese Association for Acute Medicine ·Koichiro Abe, Masanari Kato, (unknown), Masayoshi Nishimoto, (unknown), Isao Nishihara, Hiroshi Akimoto	0
8	Efficient delivery of antibody into living cells using a novel HVJ envelope vector system 2008 ·Journal of Immunological Methods ·Yoshitaka Kondo, (unknown), (unknown), (unknown), (unknown), Fuminori Kato, Masanari Kato	27
9	Trifluoromethoxy-benzylated ligands improve amyloid detection in the brain using 19F magnetic resonance imaging 2008 ·Neuroscience Research ·(unknown), Shigehiro Morikawa, (unknown), Makoto Urushitani, Hiroyasu Taguchi, Nobuaki Shirai, Koichi Hirao, Masanari Kato, (unknown), Hirohiko Kimura, (unknown), Chikako Yoshida, Takashi Okada, Mitsuo Sano, Ikuo Tooyama	22
10	Noncytotoxic ribonuclease, RNase T1, induces tumor cell death via hemagglutinating virus of Japan envelope vector 2004 ·European Journal of Biochemistry ·Shunji Yuki, Yoshitaka Kondo, Fuminori Kato, Masanari Kato, Norifusa Matsuo	17
11	Alteration of Pteridine Levels in Mouse Tissues under the Exposure to Circularly Polarized Magnetic Field 2001 ·Yuta Yamaguchi, Akiko Miwa, Yoshio Yoshida, Masahiro Masada, Tsukasa Shigemitsu, Masanari Kato	0
12	Synthesis and Antitumor Activities of Water-Soluble Benzoylphenylureas. 1999 ·Chemical and Pharmaceutical Bulletin ·Hiroshi Okada, Masanari Kato, (unknown), Kazuhiko Mizuno	21
13	Nonpeptide small-molecular inhibitors of dipeptidyl peptidase IV: N-phenylphthalimide analogs 1999 ·Bioorganic & Medicinal Chemistry Letters ·Rumiko Shimazawa, (unknown), Fuminori Kato, Masanari Kato, Yuichi Hashimoto	23
14	Potent Homophthalimide-Type Inhibitors of B16F10/L5 Mouse Melanoma Cell Invasion. 1999 ·Biological and Pharmaceutical Bulletin ·Hiroyuki Kagechika, Masato Komoda, Yasuyuki Fujimoto, Yukiko Koiso, (unknown), Shizuo Kadoya, (unknown), Fuminori KATO, Masanari Kato, Yuichi Hashimoto	10
15	Novel Small Molecule Nonpeptide Aminopeptidase N Inhibitors with a Cyclic Imide Skeleton 1999 ·Journal of enzyme inhibition ·Rumiko Shimazawa, (unknown), Yasuyuki Fujimoto, Masato Komoda, Kosuke Dodo, Ryu Yamasaki, Ryuichi Shirai, Yukiko Koiso, (unknown), Fuminori Kato, Masanari Kato, Hiroyuki Miyachi, Yuichi Hashimoto	31
16	Antiangiogenic Activity of Tumor Necrosis Factor-.ALPHA. Production Regulators Derived from Thalidomide. 1999 ·Biological and Pharmaceutical Bulletin ·Rumiko Shimazawa, Hiroyuki Miyachi, (unknown), (unknown), Fuminori KATO, Masanari Kato, Yuichi Hashimoto	25
17	A novel human tumor necrosis factor alfa mutein, F4614, inhibits in vitro and in vivo growth of murine and human hepatoma: Implication for immunotherapy of human hepatocellular carcinoma 1998 ·Hepatology ·Yoshinari Atarashi, Satoshi Yasumura, Shuji Nambu, (unknown), Jun Murakami, Terumi Takahara, Kiyohiro Higuchi, Akiharu Watanabe, (unknown), Masanari Kato	7
18	Overcoming the Metastasis-Enhancing Potential of Human Tumor Necrosis Factor α by Introducing the Cell-Adhesive Arg-Gly-Asp Sequence 1995 ·Journal of Interferon & Cytokine Research ·(unknown), (unknown), (unknown), (unknown), Koji Nishimura, (unknown), Masanari Kato	11
19	A novel Mutein of TNFα Containing the Arg‐Gly‐Asp Sequence Shows Reduced Toxicity in Intestine 1994 ·Mediators of Inflammation ·(unknown), (unknown), (unknown), Ken Kuroda, Koji Nishimura, (unknown), Masanari Kato	11
20	A YIGSR-containing novel mutein without the detrimental effect of human TNF-? of enhancing experimental pulmonary metastasis 1992 ·Clinical & Experimental Metastasis ·(unknown), Masanari Kato, (unknown), Koji Nishimura, (unknown), (unknown), (unknown), Ken Kuroda, (unknown), (unknown), (unknown), Nobuhiro Yamada	19

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact